Entacapone Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200mg
Reference Brands: COMTAN (USA/EU), ENTACOM (EU), ENTALIN (EU)
Category:
Neurology
Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), an enzyme involved in dopamine breakdown. It is used as an adjunct to levodopa/carbidopa therapy in patients with Parkinson’s disease to prolong the effect of levodopa and improve motor control. The medicine is taken orally, usually with each levodopa dose. Its common brand name is Comtan, available as 200 mg film-coated tablets worldwide.
Entacapone is available in Tablets
and strengths such as 200mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Entacapone is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Entacapone can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing